Charles K Allam, MD

Associate Professor, Pathology & Laboratory Medicine

857.203.5898

Other Positions

  • VA Boston Healthcare System

Education

  • Saint Joseph University, MD

Publications

  • Published on 9/8/2005

    Prabhala RH, Neri P, Bae JE, Tassone P, Shammas MA, Allam CK, Daley JF, Chauhan D, Blanchard E, Thatte HS, Anderson KC, Munshi NC. Dysfunctional T regulatory cells in multiple myeloma. Blood. 2006 Jan 01; 107(1):301-4. PMID: 16150935.

    Read at: PubMed
  • Published on 8/3/2004

    Tassone P, Goldmacher VS, Neri P, Gozzini A, Shammas MA, Whiteman KR, Hylander-Gans LL, Carrasco DR, Hideshima T, Shringarpure R, Shi J, Allam CK, Wijdenes J, Venuta S, Munshi NC, Anderson KC. Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells. Blood. 2004 Dec 01; 104(12):3688-96. PMID: 15292058.

    Read at: PubMed
  • Published on 7/1/2004

    Tassone P, Gozzini A, Goldmacher V, Shammas MA, Whiteman KR, Carrasco DR, Li C, Allam CK, Venuta S, Anderson KC, Munshi NC. In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells. Cancer Res. 2004 Jul 01; 64(13):4629-36. PMID: 15231675.

    Read at: PubMed
  • Published on 7/1/1996

    Allam CK, Bostwick DG, Hayes JA, Upton MP, Wade GG, Domanowski GF, Klein MA, Boling EA, Stilmant MM. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma. Mod Pathol. 1996 Jul; 9(7):742-51. PMID: 8832557.

    Read at: PubMed
  • Published on 9/1/1994

    Johnson CL, Gerson B, Nunez M, Allam C. Field evaluation of the NOVA Celltrak 12 hematology analyzer. Am J Clin Pathol. 1994 Sep; 102(3):306-9. PMID: 8085553.

    Read at: PubMed

View all profiles